Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies

Fig. 3

Immunohistochemistry of BD cell line showing strong expression of CD18, vimentin, and CD204, while being negative for CD3 and CD79a expression (left column). Middle and right columns are negatitve control and positive control sections, respectively. For CD18, CD204, CD3 and CD79a antibodies, DAB chromogen was used; and for vimentin antibody, alkaline phosphatase red chromogen. Calibration bar: 50 μm

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us